Viewing Study NCT04922593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-02-06 @ 3:40 AM
Study NCT ID: NCT04922593
Status: COMPLETED
Last Update Posted: 2023-04-25
First Post: 2021-04-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Relative Bioavailability of LY03010 Compared to Listed Drug
Sponsor: Luye Pharma Group Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Psychotic Disorders View
None Mood Disorders View
None Schizophrenia Spectrum View
None Mental Disorders View
None Antipsychotic Agents View
None Tranquilizing Agents View
None Central Nervous System Depressants View
None Physiological Effects of Drugs View
None Psychotropic Drugs View
None Neurotransmitter Agents View
None Molecular Mechanisms of Pharmacological Action View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None Paliperidone Palmitate View
None Serotonin 5-HT2 Receptor Antagonists View
None Serotonin Antagonists View
None Serotonin Agents View
None Dopamine D2 Receptor Antagonists View
None Dopamine Antagonists View
None Dopamine Agents View